Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Last Updated: March 24, 2023

Details for New Drug Application (NDA): 016763

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

NDA 016763 describes SULFAMYLON, which is a drug marketed by Rising and Mylan Institutional and is included in two NDAs. It is available from two suppliers. Additional details are available on the SULFAMYLON profile page.

The generic ingredient in SULFAMYLON is mafenide acetate. There are four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the mafenide acetate profile page.
Summary for 016763
Ingredient:mafenide acetate
Formulation / Manufacturing:see details
Pharmacology for NDA: 016763
Medical Subject Heading (MeSH) Categories for 016763
Suppliers and Packaging for NDA: 016763
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SULFAMYLON mafenide acetate CREAM;TOPICAL 016763 NDA Rising Pharma Holdings, Inc. 16571-723 16571-723-12 1 TUBE in 1 CARTON (16571-723-12) / 113.4 g in 1 TUBE
SULFAMYLON mafenide acetate CREAM;TOPICAL 016763 NDA Rising Pharma Holdings, Inc. 16571-723 16571-723-48 453.6 g in 1 JAR (16571-723-48)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrengthEQ 85MG BASE/GM
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.